Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.

In a world inundated with weight loss solutions, finding a reliable and effective option can be challenging. Mitolyn emerges ...

The U.S., Uruguay, and Venezuela have the highest rates of gun-related suicides. The U.S. has almost double the number of gun ...

In today’s fast-paced world, maintaining a healthy lifestyle can be challenging, especially when it comes to managing weight ...

GLP-1 receptor agonists, initially developed for type 2 diabetes treatment, work by mimicking a naturally occurring gut ...

You can add it to your coffee, cook it fresh or pop as a pill – but does this popular mushroom actually supercharge your ...

State Senate holds a hearing on a controversial proposal to restrict diet pills and supplements for those under 18.

As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

It's no secret that protein is a key nutrient for weight loss and overall health. While protein shakes and powders offer a ...

About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

Lilly's retatrutide shows remarkable weight loss in trials but raises concerns with side effects possibly linked to the drug like nausea and kidney stones. Read more here.